EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) Stock Price, Quote, News & History

Key Statistics

Open

Volume / Avg.

0 / 15.31K

Day Range

- - -

52 Wk Range

0.00 - 3.73

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

110.36

Recent Eagle Pharmaceuticals Inc News

Crude Oil Edges Higher; ConAgra Posts Downbeat Earnings

Avi Kapoor

Dow Gains 100 Points; Joby Aviation Shares Spike Higher

Avi Kapoor

US Stocks Edge Lower; Private Employment Beats Expectations

Avi Kapoor

Why Patterson Companies Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Patterson Companies, Inc. (NASDAQ: PDCO) moved lower during Wednesday’s session after the company reported worse-than-expected second-quarter financial results and lowered FY24 adjusted EPS guidance below estimates.

Lisa Levin

Why Is Eagle Pharmaceuticals Stock Trading Lower Today?

Eagle Pharmaceuticals Inc's (NASDAQ: EGRX) Scott Tarriff, founder, president, and Chief Executive Officer, announced his resignation and retirement,

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-9.32M

Investing Cash Flow (TTM)

-23.81M

Financing Cash Flow (TTM)

11.92M

Free Cash Flow (TTM)

-9.39M

Capital Expenditure (TTM)

-74.00K

Net Change in Cash (TTM)

-21.21M

Valuation Metrics

Enterprise Value

$7.83M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$70.19M

LT Debt

$61.90M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$50.74M

Total Cash

$15.35M

Debt to Equity

0.28

Issuance of Debt (TTM)

-$736.00K

Repayment of Debt (TTM)

-$85.74M

Key Statistics

Open

Volume / Avg.

0 / 15.31K

Day Range

- - -

52 Wk Range

0.00 - 3.73

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

110.36

About

Sector

Health Care

Industry

Biotechnology

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argat...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EGRX

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

EGRX

FAQ

How do I buy EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) stock?

You can purchase shares of EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (OTCEM:EGRX) through any online brokerage.

View our list of the best stock brokerages

Who are EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) competitors?

There are no as such competitors for EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc..

What is the forecast, or price target, for EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) stock?

There is no analysis for EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. to provide a consensus price target.

What is the current price for EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX)?

The stock price for EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (OTCEM: EGRX) is $0.595 last updated August 12, 2026 at 1:37 PM EDT.

Does EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) pay a dividend?

There are no upcoming dividends for EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc..

When is EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (OTCEM:EGRX) reporting earnings?

EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. does not have any upcoming earnings scheduled.

Is EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) going to split?

There is no upcoming split for EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc..

What sector and industry does EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. (EGRX) operate in?

EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.